← Open Payments lookup

WEI ZHU: Open Payments

NPI 1104234863 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$998 in 23 payments from 12 companies in 2025. Trend: 2023 $811 · 2024 $1,093 · 2025 $998

Food & beverage: $998
CompanyPaymentsAmount
Astellas Pharma US Inc3$203
Incyte Corporation3$183
Syndax Pharmaceuticals, Inc.4$131
Adaptive Biotechnologies Corporation1$118
SOBI, INC3$98
Merck Sharp & Dohme LLC2$62
Celgene Corporation2$55
AstraZeneca Pharmaceuticals LP1$33
Rigel Pharmaceuticals, Inc.1$32
Takeda Pharmaceuticals U.S.A., Inc.1$30

Products named: JAKAFI, Xospata, clonoSEQ, REBLOZYL, Vonjo, CALQUENCE, TAVALISSE, Gamifant.

Industry payments across TX — which companies pay providers there.